ArticleJournal of fluorescence2025
1,3,4-Oxadiazole Derivative: Gelation Induced Emission Enhancement and Triple-Channel Acid Responsive Properties.
Article in Journal of fluorescence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
In recent years, luminescent materials with stimuli-responsive properties have attracted extensive attention. In this article, the gelation induced emission enhancement (GIEE) property of an 1,3,4-oxadiazole derivative (4-POXD-B8) was studied. The formation of the J-aggregate was viewed as the reason for this GIEE property, which was proved by UV-vis spectra. 4-POXD-B8 was found to exhibit a triple-channel (color, fluorescence and state change) response to trifluoroacetic acid (TFA). It was speculated that the reason for the acid responsiveness of 4-POXD-B8 was that the molecule was protonated after the addition of TFA, which can be confirmed by 1 H NMR and UV-vis spectra. In addition, the encryption-decryption process of information under visible and UV light was realized by using 4-POXD-B8 and TFA/triethylamine (TEA), which may provide some reference for future information storage.
Indexed as
Identifiers
40542986What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.